Catalyst Wire Dossier Catalyst Wire Dossier

Flutiform K-haler

· Mundipharma Korea Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Flutiform K-haler, covering 2021-01-25 to 2021-01-25. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Flutiform K-haler in Patients With Uncontrolled Asthma Following Mid-dose ICS/LABA DPI Therapy [Phase 3]

See pricing